The global Antisense And Ribonucleic Acid Interference (Rnai) Therapeutic Market was valued at USD 1.26 billion in 2022. It is projected to witness significant growth and reach USD 2.13 billion by 2032, with a steady revenue compound annual growth rate (CAGR) of 6% during the forecast period.